STANKOVICH THOMAS 4
4 · ReShape Lifesciences Inc. · Filed Aug 13, 2024
Insider Transaction Report
Form 4
STANKOVICH THOMAS
Chief Financial Officer
Transactions
- Sale
Common Stock, $0.001 par value per share
2023-11-30$0.23/sh−39$9→ 22,910 total - Sale
Common Stock, $0.001 par value per share
2024-02-29$0.17/sh−43$7→ 22,825 total - Sale
Common Stock, $0.001 par value per share
2023-12-31$0.25/sh−42$11→ 22,868 total - Sale
Common Stock, $0.001 par value per share
2024-05-31$0.25/sh−48$12→ 22,777 total
Footnotes (1)
- [F1]On July 22, 2021, Mr. Stankovich was awarded an aggregate of 7,455 restricted stock units, all of which, including the unvested portion, were reported on a Form 4 filed on September 17, 2021. The shares reported under this Form 4 as being disposed of were sold to cover taxes in connection with the vesting of a portion of those previously reported restricted stock units.